1009 Hydrochloroquine. De wereld is enthousiast.

Dr Stephen Smith,  New Jersey.
Ingraham. 4 min.  interview op 2 april

UPDATE: eerst stond hier de korte versie van het intervieuw, met alleen de HCQ info, en zonder de 'diabetic' en  'obese'  info.  Nu staat hier de goede video.

Samenvatting:

De patienten: diabeten en zwaarlijvigen.

(De schrijver van dit blog is 68, heeft een BMI van 30 en  is licht diabetisch. 
Drie rode kruisjes achter mijn naam. 
Als ik besmet wordt heb ik echt die HCQ nodig. 
Maar die kan de arts niet geven, want ja, "U zou wel eens misselijk kunnen worden !"
Ze voeren de agenda uit van Big Pharma, maar ze weten het echt niet.

Ik hoor het de Rockefellers cs gewoon zeggen: "We need more educated fools. No clever journalists, epidemiologists, politicians or bankers  please. 
Intelligent fools, thats what we need ! People with a big ego and lots of vanity.  

You prime them with our version of the world, and their vanity and confirmtion bias  will keep them in that bubble forever. 
They will die like the Black Knight, unable to see that they are wrong." 


Dr Smith zegt dat zijn Covid-19 patienten vaak diabetes hebben, of bijna diabetes patient zijn.
Ook zijn erg veel patienten obese.  Jongere mensen lopen alleen risico op Covid-19 als obese zijn.

De remedie:  Hydrochloroquine in vroeg stadium.
Dr Smith is heel erg enthousiast over HCQ.
Hij moest 20 patienten intuberen (aan de beademing leggen)   in 2 dagen tijd, maar daar was niemand bij die HCQ kreeg.


Dit is de tekst bij de video:

Malaria drug hydroxychloroquine continues to dominate the headlines after many success stories from doctors in the front line. This evening, a renowned infectious disease specialist Dr. Stephen Smith, said he and his team have treated over the 50 patients with hydroxychloroquine. Dr. Smith is the founder of the Smith Center for Infectious Diseases in New Jersey.

Tonight, Dr. Smith shared his findings among COVID-19 patients in an interview with Fox News host Laura Ingraham. He pointed out that not a single COVID-19 patient, that has been under hydroxychloroquine regimen, has had to to be intubated. Dr. Smith said his team had 20 intubations that all occurred within two days. But more importantly, Dr. Smith said no person who received hydroxychloroquine for 5 days or more had been intubated.

“The more we see this disease, the more we understand that severe rapid COVID disease is in diabetics or prediabetics … we don’t have anyone in our group over 80 that was not diabetic or pre-diabetic that was intubated,” said the founder of the Smith Center for Infectious Diseases and Urban Health. And of the younger patients that had severe disease, he explained they had very high BMIs.

“We haven’t had anyone under 70 who didn’t have a very high BMI, or was pre or diabetic, get seriously ill,” he said. “This is amazing stuff.” When the two discussed treatment options and the use of hydroxychloroquine and azithromycin, Smith said they are treating everyone with it and it has had incredible results. “No person who has received five days or more or the [drug] combination has been intubated,” he said.

He added that the chance of intubation happening, based on the stat done by his son, is a ridiculously low number of about 0.000-something. “The chance of that occurring by chance…are .000-something, it’s ridiculously low no matter how you look at it,” he said.

Dr. Smith went on to say that his team’s data support the data from French study led by the famous French researcher Dr. Didier Raoult. “[Hydroxychloroquine] is a game changer. I think this is the beginning of the end of the [coronavirus] pandemic,” Dr. Smith concluded.

Dr. Stephen Smith is an infectious disease specialist in Roseland, New Jersey and is affiliated with multiple hospitals in the area. He has been in practice for more than 20 years.

Below is a video of his interview with Fox News host Laura Ingraham.

         ===============================================

Nog een interview met een andere arts in de VS:
Opmerkelijk: deze Dr Jeff Coyler was ooit gouverneur van Kansas.

  
Min 4: "If you treat them early, they tend to get better fast."

Min 6.30: Dr Oz:  "Wat adviseert U aan collega's? Sommigen zeggen 'Ik wil wachten op de onderzoeksresulta
ten van HCQ oo rik het voorschrijf".
Dr Coyler: "20%  van de medicijnen die wij voorschrijven zijn eigenlijk noet voor die kwaal gemaakt.  Off-label use dus. ( Hij bedoelt: dit bezwaar tegen off label use is een beetje vreemd).  "We zien de wetenschap en de C19 kennis heel snel ontwikkelen. Er zullen ook wel wat studies komen die minder positief zijn.   Maar je moet de grote lijnen zien en je afvragen: "Wat is het beste voor mijn patienten? Welke data heb ik nu ? De FDA heeft het nu toegestaan.  Er zijn nu vele ziekenhuizen die het gebruiken. "

Dr Oz: "Wil U het ook voor uzelf gebruiken uit voorzorg? "
Coyler: "Er zij nu nog te weinig pillen, maar er wordt heel snel bij geproduceerd. We moeten zorgen dat de patienten met Rheumatoide arthritis dat medicijn krijgen.  En ja, daarna zijn eel van mijn collega's geïntereseerd om dit medicijn als profylax te ontvangen" 
Dr Coyler wil dan zelf het HCQ ook uit voorzorg te nemen.

Dr Oz:  HCQ voorkomt dat het virus in de cel komt, maar het remt ook een over-acief immuun systeem af.  ( Voorkomt cytokinestorm) 


Goed nieuws:  Ook in Amerika is er kans dat Big Pharma  het HCQ niet tegen kan houden. 


   ==============================================
De website van Sermo:

Moving medicine forward, one conversation at a time

Our mission is to revolutionize real world medicine

Sermo is een website die gesprekken tussen 800.000 artsen wereldwijd mogelijk maakt, over hun vak en hun vragen. Discretie verzekerd.

Maar ze doen ook enquetes.
Zo vroegen ze al hun leden  welk medicijn volgens hen het meest belovend was om C19  te bestrijden.

HCQ kwam als beste uit de bus.

Op deze website stat het onderzoek het best weergegeven:

A global survey of more than 6,000 doctors conducted found that malarial drug hydroxychloroquine was the most highly rated treatment against the deadly coronavirus (COVID-19).

The survey conducted by Sermo, a global health care polling company, found that 6,227 physicians in 30 countries found that 37% of those treating COVID-19 patients rated hydroxychloroquine as the “most effective therapy” from a list of 15 options..

USA:  HCQ  Previously available for “off-label” use.    

Now: FDA gives hospitals and doctors emergency permission to use the anti-malarial drugs hydroxychloroquine and chloroquine to treat coronavirus patients.

The survey also found that the three most commonly prescribed treatments are 56% analgesics, 41% Azithromycin, and 33% Hydroxychloroquine.

Below is a summary of the findings.

• Hydroxychloroquine usage amongst COVID-19 treaters is 72% in Spain, 49% in Italy, 41% in Brazil, 39% in Mexico, 28% in France, 23% in US, 17% in Germany, 16% in Canada, 13% in UK and 7% in Japan. (Nederland en België staan er niet bij. Toch staat België op de 4e plaats en Nederland op plaats 5 (aantal  C19  per miljoen inwoners)  https://www.mediterranee-infection.com/covid-19/
• 
  
• Hydroxychloroquine was overall chosen as the most effective therapy from a list of 15 options (37% of COVID-19 treaters).
• 
  
• 75% in Spain, 53% Italy, 44% in China, 43% in Brazil, 29% in France, 23% in US and 13% in UK.
• 
  
• The two most common treatment regimens for Hydroxychloroquine were:  (38%) 400mg twice daily on day one; 400 mg daily for 5 days. (26%) 400mg twice daily on day one; 200mg twice daily for 4 days.
• 
  
• Outside the US, Hydroxychloroquine was equally used for diagnosed patients with mild to severe symptoms whereas in the US it was most commonly used for high risk diagnosed patients.
• ( Ik vermoed dat Dr Stephen Smith  het ook voor minder ernstige patienten gebruikt.)  
• 
  
• Globally, 19% of physicians prescribed or have seen Hydroxychloroquine prophylactically used for high risk patients, and 8% for low risk patients.
• 
  
• Second global outbreak is anticipated by 83% of global physicians, 90% of US physicians but only 50% of Chinese physicians.
• 
  
• In the US, 63% of physicians recommend restrictions be lifted six or more weeks from now and 66% believe the peak is at least 3-4 weeks away.
• 
  
• Average Time for COVID-19 Test:
  • On average tests in the US take 4-5 days, and in 10% of cases the wait is more than 7 days.
  • 14% of US physicians and over 50% in all of Europe and Japan report getting test results in 24 hours; in China 73% of doctors get tests back in 24 hours, while 8% get tests back within the hour.
• 
  
• Prioritizing Patient Treatment in Case of Ventilator Shortage:  
• • In all countries except China, the top criteria for deciding who should receive a ventilator first was patients with the highest chance of recovery (47%) followed by those most ill and at highest risk of death (21%), then first responders (15%).
  • In China the priorities were reversed as the most ill and highest risk of death received ventilators.
  • First responders were more important in the US.
  • France, Japan, and Italy prioritized age.
  • Brazil and Russia prioritized higher risk patients.